Aspire Home Health Location: 1020 West Atherton Drive, Suite 220, Taylorsville, Utah 84123 Ratings: Phone: (801) 292-0296 Health Services: Nursing Care, Physical Therapy, Occupational Therapy, Speech Pathology, Medical Social Services, Home Health Aide |
News Archive
President Obama signed into law the bipartisan Food and Drug Administration (FDA) Safety and Innovation Act (FDASIA) on July 9.
Tulsa CARES is partnering with researchers at the Hudson College of Public Health at the University of Oklahoma Health Sciences Center and the OU-TU School of Community Medicine at the University of Oklahoma to develop and test a novel "food as medicine" intervention for individuals affected by HIV/AIDS.
Elite endurance athletes who eat very few carbohydrates burned more than twice as much fat as high-carb athletes during maximum exertion and prolonged exercise in a new study - the highest fat-burning rates under these conditions ever seen by researchers.
Covidien, a leading global provider of healthcare products, today announced CE Mark approval for its EverFlex Self-expanding Peripheral Stent with Entrust Delivery System.
BELLUS Health Inc. and Celtic Therapeutics announced today that a global confirmatory phase III clinical study was initiated on December 14, 2010 for KIACTA™ (eprodisate). KIACTA™ is a drug candidate being developed for the treatment of AA amyloidosis, a life-threatening orphan disease that occurs in patients with long-lasting inflammatory conditions, most commonly due to rheumatoid arthritis. The study is designed to confirm the safety and efficacy of KIACTA™ in preventing renal function decline in patients with AA amyloidosis.
› Verified 5 days ago